The Cancer Genome Atlas (TCGA) study was the first landmark study to describe the mutation of EIF1AX in thyroid tumors, more specifically in papillary thyroid carcinoma (PTC) [8]. The gene discussed is EIF1AX; the disease is differentiated thyroid carcinoma.